Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux*

Scavenger receptor BI (SR-BI) binds high density lipoproteins (HDL) with high affinity and mediates the selective uptake of HDL cholesteryl ester. We examined the potential role of SR-BI in mediating cellular cholesterol efflux. In Chinese hamster ovary cells stably transfected with murine SR-BI, overexpression of SR-BI resulted in a 3–4-fold stimulation of initial cholesterol efflux rates. Efflux rates correlated with SR-BI expression in cells and HDL concentration in the medium. When incubated with synthetic cholesterol-free HDL, SR-BI-transfected cells showed ∼3-fold increases in initial rates of efflux compared with control cells, indicating that SR-BI expression enhances net cholesterol efflux mediated by discoidal HDL. In six different cell types, including cultured macrophages, the rate of efflux of cholesterol mediated by HDL or serum was well correlated with cellular SR-BI expression level. In addition, in situhybridization experiments revealed that SR-BI mRNA was expressed in the thickened intima of atheromatous aorta of apolipoprotein E knockout mice. Thus, SR-BI is an authentic HDL receptor mediating cellular cholesterol efflux. SR-BI may facilitate the initial steps of HDL-mediated cholesterol efflux in the arterial wall as well as later steps of reverse cholesterol transport involving uptake of HDL cholesterol in the liver.

[1]  M. Phillips,et al.  Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. , 1997, The Journal of clinical investigation.

[2]  W. J. Johnson,et al.  Cholesterol transport between cells and high-density lipoproteins. , 1991, Biochimica et biophysica acta.

[3]  A. Tall Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. , 1990, The Journal of clinical investigation.

[4]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[5]  E. Edelman,et al.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.

[6]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[7]  A. Jonas Reconstitution of high-density lipoproteins. , 1986, Methods in enzymology.

[8]  D. B. Zilversmit,et al.  A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. , 1981, The Journal of biological chemistry.

[9]  W. J. Johnson,et al.  Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. , 1995, Biochemistry.

[10]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[11]  W. J. Johnson,et al.  Cellular Cholesterol Efflux Mediated by Cyclodextrins , 1996, The Journal of Biological Chemistry.

[12]  P. Giral,et al.  A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  K. Williams,et al.  Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. , 1996, The Journal of clinical investigation.

[14]  W. J. Johnson,et al.  Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. , 1992, Journal of lipid research.

[15]  M. Phillips,et al.  Reverse cholesterol transport. , 1986, Methods in enzymology.

[16]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[17]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[18]  A. Rigotti,et al.  Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. , 1996, The Journal of clinical investigation.

[19]  A. Tall,et al.  Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.

[20]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[21]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[22]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[23]  A. Tall,et al.  Scavenger Receptor BI (SR-BI) Is Up-regulated in Adrenal Gland in Apolipoprotein A-I and Hepatic Lipase Knock-out Mice as a Response to Depletion of Cholesterol Stores , 1996, The Journal of Biological Chemistry.

[24]  W. J. Johnson,et al.  Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. , 1992, Journal of lipid research.

[25]  S. Yokoyama,et al.  Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. , 1996, Journal of lipid research.

[26]  A. Mendez,et al.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. , 1994, The Journal of clinical investigation.

[27]  A. Tall Plasma lipid transfer proteins. , 1995, Annual Review of Biochemistry.

[28]  A. Ross,et al.  Selective inhibition of acyl coenzyme A:cholesterol acyltransferase by compound 58-035. , 1984, The Journal of biological chemistry.

[29]  J. Weinstein,et al.  Acetoacetylated Lipoproteins Used to Distinguish Fibroblasts from Macrophages In Vitro by Fluorescence Microscopy , 1981, Arteriosclerosis.

[30]  P. Duchateau,et al.  Transfer of cholesterol from Ob1771 cells or LDL to reconstituted, defined high density lipoproteins. , 1994, Journal of lipid research.

[31]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.